Kilpatrick Townsend & Stockton LLP
Pharmaceutical composition for oral use with improved absorption
The present invention relates to an agent for inhibiting decomposition of a biologically active peptide by a digestive enzyme, which is aminoalkyl methacrylate copolymer E as an effective ingredient, and an agent for reducing viscosity of the gastrointestinal mucosa and mucous layers distributed over this mucosa. The present invention relates to a method for inhibiting decomposition of a biologically active peptide by a digestive enzyme, or a method for reducing viscosity of the gastrointestinal mucosa and/or mucous layers distributed over the mucosa, by administration of aminoalkyl methacrylate copolymer E. Furthermore, the present invention relates to a pharmaceutical composition for oral use with improved absorption, which comprises a biologically active peptide and aminoalkyl methacrylate copolymer E. Excellent oral absorption of a biologically active peptide that were considered difficult to absorb by oral administration in the past, can be realized based on the ability to inhibit decomposition of a biologically active peptide, the ability to reduce viscosity of the gastrointestinal mucosa and/or mucous layers distributed over this mucosa, and the ability to improve permeability of a biologically active peptide in the gastrointestinal mucosa and/or mucous layers of the pharmaceutical composition of the present invention.
Astellas Pharma Inc.
A A A A A A A A A A A A A A
A61K A61K A61P A61K A61P A61K A61K A61K A61P A61K A61K A61K A61P A61K
inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional additional inventional inventional
Kiyo Shunsuke Yuuki Shigeo
Nakanishi Watanabe Tsutsui Takemura